Taken together, our data suggest that the mechanical properties of utrophin may be tuned by phosphorylation, with the potential to improve its efficacy as a protein replacement therapy for dystrophinopathies. The gene discussed is UTRN; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.